March 17, 2014

Accenture Positioned as a Leader in an IDC MarketScape: Worldwide Life Sciences Research & Development Vendor Assessment on Strategic Consulting Services


NEW YORK; March 17, 2014 – Accenture (NYSE:ACN) is positioned as a Leader in an IDC Health Insights IDC MarketScape vendor assessment covering strategic consulting services across the life sciences research and development (R&D) industry.

The report, “IDC MarketScape: Worldwide Life Science R&D Strategic Consulting Services 2014 Vendor Assessment" (#HI246518), provides an assessment of the life science R&D industry and market trends, comparing major vendors and assesses the criteria that are most important for life science companies to consider when selecting a service provider. It is the seventh time that Accenture has been positioned as a Leader in recent IDC MarketScapes.

In naming Accenture as a Leader, the IDC MarketScape stated, “Relative to other vendors discussed in this report, and based on feedback from multiple customer references, Accenture received high marks for understanding the specific needs of the life science industry and for being a high-quality service provider with both full life-cycle offerings and global capacity, including on-the-ground resources in emerging regions.”

“This latest Leader endorsement, this time for our strategic consulting capabilities, follows similar Leader designations in the R&D business process outsourcing and R&D technology outsourcing space by IDC Health Insights,” said Henry Levy, managing director in Accenture’s Life Sciences R&D practice. “We recognize there is a strong demand for strategic consulting services in the life sciences industry as pharmaceutical companies continue to transform themselves to remain competitive. Accenture provides pharmaceutical/life sciences clients with a fully-integrated, technology enabled business service that helps them improve R&D cross-functional processes, insights and outcomes.”

For the purposes of this analysis, IDC Health Insights divided potential key measures for success into two primary categories: capabilities and strategies. The assessment includes client references. A total of 14 vendors participated in the vendor assessment. Accenture has also been positioned as a Leader in six other recent IDC MarketScapes. These are:

Click here to learn more about Accenture’s Life Sciences practice.

About Accenture
Accenture is a global management consulting, technology services and outsourcing company, with approximately 281,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world’s most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$28.6 billion for the fiscal year ended Aug. 31, 2013. Its home page is www.accenture.com .

About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

# # #



Contact:

Cam Granstra
Accenture
+ 312 693 5992
cameria.l.granstra@accenture.com